ArticleDie Ophthalmologie2025
[Retreatment after keratorefractive lenticule extraction (KLEx) : Results of various methods and influence of the recommendations of the Committee for Refractive Surgery (KRC) on the incidence of retreatment].
Article in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CLEAR Lenticule Extraction for Enhancement After Primary Lenticule Extraction Surgery.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKeratorefractive lenticule extraction (KLEx) has been shown to be safe and effective for the correction of myopia and myopic astigmatism. Residual refractive errors reduce the uncorrected postoperative visual acuity leading to patient dissatisfaction and increased retreatment rates. AIM OF THE STUDY: The aim was to assess the potential influence of the recommendations of the Committee for Refractive Surgery (KRC) on the likelihood of retreatment and to compare the results of various methods for retreatment after KLEx for myopia.
methodsRetrospective study of eyes with myopia and myopic astigmatism in which KLEx (SMILE, Visumax 500, Carl Zeiss Meditec, Jena, Germany) was performed between April 2015 and December 2022.
resultsA total of 2462 eyes from 1278 patients were analyzed. Of the eyes 3.05% (n = 75) were retreated within 24 months. Eyes in the recommended treatment range (corrections up to -8.0 dpt in the stronger main section) had a 50% lower risk of retreatment than eyes within the borderline range (corrections between -8.0 dpt and -10.0 dpt in the stronger main section). Retreatment was predominantly performed using the advanced surface ablation (ASA n = 44) or the Circle program (transformation of a SMILE cap into a flap, n = 29). The postoperative results of both methods after 3 months were comparably safe and effective; however, visual recovery was significantly faster with Circle. A second KLEx treatment in two eyes (one patient) resulted in a residual refractive error, which impaired the uncorrected visual acuity even 1.7 years later.
conclusionThere was a significantly lower retreatment rate in the recommended treatment range than in the borderline range according to the KRC recommendations. In addition, the ASA and Circle proved to be equally predictable but with different healing processes. These results can help with the education and selection of patients.
Indexed as
Identifiers
40323398What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.